![]() ![]() Adjusted to exclude 1-time items, including a pension settlement and expenses from the acquisition, earnings per share were 83¢, 6¢ ahead of expectations on Wall Street, where analysts were looking for sales of $488.7 million. 30, representing a -72.0% profit slide on sales growth of 5.9% compared with Q2 2014. Steris last week posted profits of $8.7 million, or 14¢ per share, on sales of $489.9 million for the 3 months ended Sept. “This combination marks a significant milestone for STERIS, creating a stronger global leader in infection prevention and sterilization, better-positioned to provide comprehensive solutions to medical device companies, pharmaceutical companies, hospitals and other healthcare facilities around the world,” president & CEO Walt Rosebrough said in prepared remarks. Shares of the new Steris are due to begin trading under its STE symbol on the New York Stock Exchange tomorrow, the company said. and Synergy, and the FTC has formally dismissed the administrative complaint.” 30 “to not pursue further administrative proceedings challenging the combination between Steris Corp. Today the Mentor, Ohio-based company said the FTC decided Oct. Federal Trade Commission’s bid to block the pending, $1.9 billion merger. ![]() Last month a federal judge today shot down the U.S. Federal Trade Commission last week abandoned its bid to block the union. As expected, Steris (NYSE: STE) said today that it closed a $2 billion merger with the U.K.’s Synergy Health, after the U.S. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |